Figure. Overview of current and in development antiplatelet agents. COX-1 indicates cyclooxygenase-1; GPVI, glycoprotein VI; PAR1, protease-activated receptor-1; PDE, phosphodiesterase; PDI, protein ...
Taylor Fox is the Outdoor Gear Editor at Travel + Leisure where she tests, researches, and writes about travel products. Taylor holds a Master’s in Geography and has been a writer and editor for ...
Figures 7A–J shows that, Bicalutamide, BMS.509,744, Bortezomib, CMK, Docetaxel, Doxorubicin, erlotinib, Gemcitabine, Obatoclax. The lower the semi-inhibitory concentration of mesylate and patlactone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback